Estimated reading time: 2 minutes
Physical cannabis exchange, Canxchange, has entered into a partnership with cannabis consultants EPC Healthcare Gmbh.
London-based Canxchange will begin adding global pharmaceutical companies and medical organisations to their member network with the help of EPC Healthcare. The partnership will uncover and highlight business opportunities for the field.
Businesses in the sector will now have access to the technology and services needed to accelerate their procurement and supplier onboarding processes, while simultaneously benefitting from a secure payment solution and due diligence tools.
Read more: Canxchange launches new trading system for the cannabis market
Canxchange CEO & co-founder, Alex Arkentis, commented: “Our entry into medical cannabis has been two years in the making and is an integral part of our strategy. The main objective of this launch is to encourage the production and distribution of medical cannabis globally.
“Our strategic partner, EPC Healthcare GmbH, has been invaluable in helping Canxchange enter the sector and gain access at the highest levels.”
EPC is represented by experienced pharma specialists Klaus-Jürgen Preuss and Martin Zentgraf. Both are medical doctors by education and have been active for many years in leading roles in the pharmaceutical and medical device industry, with a specific focus on medical cannabis most recently.
Preuss and Zentgraf commented: “Since the legalisation of medical cannabis in Germany, we have seen increasing demand for quality products year after year.
Read more: Canxchange explores the global pricing of hemp
“This trend will continue as other countries are taking a more liberal stance and with the potential of legal recreational usage. The discrepancy between availability of quality cannabis and demand will continue to grow in Europe and Canxchange is well-positioned to fill these gaps.”
The announcement comes following the company’s success in implementing a market infrastructure for hemp-derived transactions, where they will continue to operate and equally invest.
[activecampaign form=31]
